[HTML][HTML] A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation

S Mehdi, SUD Wani, KL Krishna, N Kinattingal… - … and Biophysics Reports, 2023 - Elsevier
Stress is a disturbance in homeostasis caused by psychological, physiological, or
environmental factors. Prolonged reactions to chronic stress can be detrimental, resulting in …

Novel melatonin-based therapies: potential advances in the treatment of major depression

IB Hickie, NL Rogers - The Lancet, 2011 - thelancet.com
Major depression is one of the leading causes of premature death and disability. Although
available drugs are effective, they also have substantial limitations. Recent advances in our …

Gender patterns in borderline personality disorder

RA Sansone, LA Sansone - Innovations in clinical …, 2011 - pmc.ncbi.nlm.nih.gov
Gender differences in patients with borderline personality disorder are potentially relevant
because they may guide clinicians in assessment and treatment. To date, a number of …

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies

D Taylor, A Sparshatt, S Varma, O Olofinjana - Bmj, 2014 - bmj.com
Objective To systematically review published and unpublished efficacy studies of
agomelatine in people with depression. Design Systematic review and meta-analysis. Data …

Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder

J Pierre Olié, S Kasper - International Journal of …, 2007 - academic.oup.com
Current antidepressants used in major depressive disorder (MDD) are still not efficacious
enough for many patients due to high levels of treatment resistance and bothersome side …

Depression subty** based on evolutionary psychiatry: Proximate mechanisms and ultimate functions

MJ Rantala, S Luoto, I Krams, H Karlsson - Brain, Behavior, and Immunity, 2018 - Elsevier
Major depressive disorder constitutes one of the leading causes of disability worldwide.
However, it is not a unitary disease—it is a heterogeneous syndrome, with patients differing …

A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or …

SA Montgomery, RZ Nielsen… - Human …, 2014 - Wiley Online Library
Objective This randomised, double‐blind, 12‐week study compared efficacy and tolerability
of flexible‐dose treatment with vortioxetine (10–20 mg/day) versus agomelatine (25–50 …

Circadian rhythms and depression: human psychopathology and animal models

N Kronfeld-Schor, H Einat - Neuropharmacology, 2012 - Elsevier
Most organisms (including humans) developed daily rhythms in almost every aspect of their
body. It is not surprising that rhythms are also related to affect in health and disease. In the …

Application of antidepressants in depression: a systematic review and meta-analysis

Z Yuan, Z Chen, M Xue, J Zhang, L Leng - Journal of Clinical Neuroscience, 2020 - Elsevier
Background The type and quantities of antidepressants are increasing, but the efficacy and
safety of first-line and emerging drugs vary between studies. In this article, we estimated the …

Major depressive disorder, sleep EEG and agomelatine: an open-label study

MAQ Salva, B Vanier, J Laredo, S Hartley… - International journal …, 2007 - academic.oup.com
This open study evaluates the effect of agomelatine, a melatonergic receptor agonist and 5-
HT2C antagonist antidepressant, on sleep architecture in patients suffering from major …